Cart
sales@molnova.com
KFM19
CAS No. 133058-72-7
KFM19( —— )
Catalog No. M33392 CAS No. 133058-72-7
KFM19 is a potent and selective adenosine receptor (A1-receptor) antagonist (IC50 : 50 nM) for the study of neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 90 | In Stock |
|
| 10MG | 131 | In Stock |
|
| 25MG | 247 | In Stock |
|
| 50MG | 356 | In Stock |
|
| 100MG | 507 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKFM19
-
NoteResearch use only, not for human use.
-
Brief DescriptionKFM19 is a potent and selective adenosine receptor (A1-receptor) antagonist (IC50 : 50 nM) for the study of neurological disorders.
-
DescriptionKFM19 is a potent, selective Adenosine receptor (A1-receptor) antagonist, with an IC50 of 50 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdenosine Receptor
-
RecptorAdenosine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133058-72-7
-
Formula Weight318.37
-
Molecular FormulaC16H22N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (314.10 mM; Ultrasonic )
-
SMILESCCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCC(=O)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. W.D. Bechtel, et al. KFM 19 antagonizes the adenosine-induced inhibition of electrically evoked acetylcholine release. Eur Neuropsychopharmacol. Sep. 1993, 3(3), Page 433
molnova catalog
related products
-
Evodenoson
Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
-
ISAM-140
ISAM-140 is a potent and highly selective antagonist of A2B adenosine receptor.
-
MRS-3777 hemioxalate
MRS-3777 hemioxalate, a selective adenosine A3 receptor antagonist, reverses the anti-injury perception effects of its corresponding agonist and serves as a valuable tool for studying inflammatory pain.
